Centerpoint Advisors’s AB InBev BUD Stock Holding History

Centerpoint Advisors’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45	Closed	-$3K	–	408
2025 Q3	$3K	Buy	+45	New	+$2.83K	﹤0.01%	387
2022 Q2	–	Sell	-4	Closed	–	–	396
2022 Q1	$0	Hold	4	–	–	﹤0.01%	409
2021 Q4	$0	Buy	+4	New	+$233	﹤0.01%	433

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

Centerpoint Advisors's BUD Position: Q4 2025 in Review

Centerpoint Advisors sold out of AB InBev (BUD) in Q4 2025, closing a stake of 45 shares — an estimated $3K sold.

Centerpoint Advisors first reported a position in BUD in Q4 2021 and held it in 3 quarters. The position peaked at $3K in Q3 2025. 535 funds tracked by Wall St. Rank hold BUD as of Q4 2025.

Centerpoint Advisors reported no remaining AB InBev position as of Q4 2025 after selling out during the quarter.
Centerpoint Advisors sold 45 AB InBev shares in Q4 2025, an estimated $3K.
Centerpoint Advisors first reported a position in AB InBev in Q4 2021 and held it in 3 quarters.
Centerpoint Advisors's AB InBev position peaked at $3K in Q3 2025.
535 funds tracked by Wall St. Rank held AB InBev as of Q4 2025.

Based on Centerpoint Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.